CN101347559A - Medicament for treating ulcer of skin - Google Patents
Medicament for treating ulcer of skin Download PDFInfo
- Publication number
- CN101347559A CN101347559A CNA2008101404331A CN200810140433A CN101347559A CN 101347559 A CN101347559 A CN 101347559A CN A2008101404331 A CNA2008101404331 A CN A2008101404331A CN 200810140433 A CN200810140433 A CN 200810140433A CN 101347559 A CN101347559 A CN 101347559A
- Authority
- CN
- China
- Prior art keywords
- parts
- medicine
- skin
- portions
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention discloses a medicine for treating skin ulceration and relates to a Chinese medicine. The medicine is prepared by the following raw materials of certain weight portions: 5 to 10 portions of borneol, 5 to 10 portions of dragon's blood and 30 to 60 portions of pearl. 2 to 10 portions of notoginseng and 1 to 5 portions of common bletilla rubber can also be added. The preparation method is as follows: the raw materials are ground into fine powder, mixed uniformly, sterilized, dried and packaged. The medicine prepared by the method of the invention has good effect on skin ulceration caused by erosion of vulva (decubitus ulcer and eczema), burn and scald, etc.
Description
Technical field:
The present invention relates to medicine, further is the Chinese medicine that is used for the treatment of skin ulceration.
Background technology:
The erosion of vulva (decubital ulcer, eczema), burn and scald are that to have a strong impact on several skins of people life sick and wounded, and the method and the medicine of many Western medicine and treatment by Chinese herbs also arranged on the market, and certain pluses and minuses are respectively arranged, and do not see specific medicament.
Summary of the invention:
The purpose of this invention is to provide a kind of medicine for the treatment of skin ulceration, its making is simple, easy to use, effect is better.
The objective of the invention is to realize by following scheme: the medicine of treatment skin ulceration is characterized in that being made by the raw material of following weight parts: each 5~10 parts of Borneolum Syntheticum, Sanguis Draxonis, 30~60 parts of Margaritas.
Preferable range is: each 6.5~8.5 parts of Borneolum Syntheticum, Sanguis Draxonis, 40~50 parts of Margaritas.
Each amounts of components of crude drug of the present invention can also be: each 5~10 parts of Borneolum Syntheticum, Sanguis Draxonis, 30~60 parts of Margaritas, 2~10 parts of Radix Notoginseng, 1~5 part of Pseudobulbus Bletillae (Rhizoma Bletillae).
Preferable range is: each 6.5~8.5 parts of Borneolum Syntheticum, Sanguis Draxonis, 40~50 parts of Margaritas, 4~8 parts of Radix Notoginseng, 2~4 parts of Pseudobulbus Bletillae (Rhizoma Bletillae).
Manufacture method: each composition medicine is ground to form fine powder, uniform mixing, sterilization after drying packing.
Borneolum Syntheticum has clearing away heat to alleviate pain, anticorrosion itching relieving effect; Margarita has the effect of granulation promoting skin care; Sanguis Draxonis has the effect of blood circulation promoting and blood stasis dispelling, promoting tissue regeneration and ulcer healing; Radix Notoginseng has the effect of styptic powder blood analgesic therapy, and Pseudobulbus Bletillae (Rhizoma Bletillae) has except that the effect of carbuncle granulation promoting analgesic.The number medicine pulls together to form the effect of anticorrosion pain relieving, blood activating and promoting tissue regeneration.
Adopt the medicine of the treatment skin ulceration that the inventive method makes, the clinical practice experience that is the inventor by for many years invents, and it all has curative effect preferably to the skin ulceration that the erosion of vulva (decubital ulcer, eczema), burn and scald etc. cause.
Testing data:
1, cures mainly: the skin ulceration that the erosion of vulva (decubital ulcer, eczema) that does not close up for a long time, burn and scald etc. cause.
2, case statistics: treat 133 examples, wherein decubital ulcer 66 examples, eczema 32 examples, burn and scald 35 examples.Among the patient, male's 75 examples, women's 58 examples, age distribution is: 9 examples below 20 years old, 20 years old~30 years old 16 example, 31 years old~40 years old 15 example, 41 years old~50 years old 32 example, 51 years old~60 years old 33 example, 28 examples more than 60 years old, maximum 72 years old age, minimal ages 5 years old, 39 years old mean age.Sick elder 60 days, weak point person 2 days, average course of disease 1 month.
3, Therapeutic Method: one day one to secondary, first behind the routine disinfection, clear skin ulcer, after medicated powder is sprayed on the skin ulcer face, cover with aseptic dressing, adhesive plaster or binder are fixed.
4, contraindication: do not have.
5, efficacy assessment standard:
Produce effects: more shallow skin ulcer face does not reach flesh layer person, and the skin ulcer face is filled by newborn connective tissue, and newborn skin possesses complete function; The skin ulcer face reaches the flesh layer deeply to the periosteum person, successively fills and leads up after the medication by newborn muscular tissue and connective tissue growth, and the parts of skin afunction, outward appearance leaves cicatrix.
Take a turn for the better: the big portion of skin ulcer face is filled and led up by newborn muscular tissue or connective tissue growth.
Invalid: as not reach improvement target person.
6, therapeutic effect:
33 days courses of treatment of mean treatment, the shortest 3 days, the longest 60 days, medication produce effects 122 examples, obvious effective rate 91.7%, 9 examples that take a turn for the better, improvement rate 6.8%, total effective rate 98.5%, invalid 2 examples, total inefficiency 1.5%.Wherein, decubital ulcer produce effects 61 examples, obvious effective rate 92.4%, 3 examples that take a turn for the better, improvement rate 4.6%, invalid 2 examples, inefficiency 3.0%; Eczema produce effects 30 examples, obvious effective rate 93.8%, 2 examples that take a turn for the better, improvement rate 6.2%, invalid 0 example; Burn and scald produce effects 31 examples, obvious effective rate 88.6%, 4 examples that take a turn for the better, improvement rate 11.4%, invalid 0 example.See following table for details:
Type | The example number | Produce effects (example) | Take a turn for the better (example) | Invalid (example) | Effective percentage % |
Decubital ulcer | 66 | 61 | 3 | 2 | 97.0 |
Eczema | 32 | 30 | 2 | 0 | 100 |
Burn and scald | 35 | 31 | 4 | 0 | 100 |
Add up to | 133 | 122 | 9 | 2 | 98.5 |
7, model case introduction:
(1) king so-and-so, man, 72 years old, Xiao Pu township, Hua County, Henan Province Jiang Zhuan people from village, improper because of the long-term bed nursing, lumbosacral region is oppressed ischemia for a long time and is formed circular skin ulcer face, diameter reaches 5 centimetres, and is dark 1.5 centimetres, no hemorrhage, sore surface ulcerated is adhered to by chequered with black and white slough, and the surrounding skin atropurpureus is distributed corrupt foul smell, bring into use this medicine in May, 2006, sprays this medicine, a twice-daily after the debridement of sterilizing routinely during use, the skin ulcer face is filled and led up by newborn connective tissue growth after January, and newborn skin possesses complete function.
(2) Liu, man, 6 years old, Hua Xianwangzhuan town, Henan Province Xing Cunren scalds two lower limb because of boiled water, and the traumatic part is for below knee more than the ankle, area 5%, shallow II degree burn, the traumatic part skin that festers is canescence, after the routine disinfection debridement, spray this medicine outward, a twice-daily, after 10 days, the healing of skin ulcer face, skin possesses complete function, and outward appearance does not have cicatrix.
The specific embodiment:
Below in conjunction with embodiment the present invention is done further narration:
Embodiment 1: the raw material of selecting following weight parts: each 5 parts of Borneolum Syntheticum, Sanguis Draxonis, 30 parts of Margaritas.
Manufacture method: each composition medicine is ground to form fine powder, uniform mixing, sterilization after drying packing.
Embodiment 2: the raw material of selecting following weight parts: each 10 parts of Borneolum Syntheticum, Sanguis Draxonis, 60 parts of Margaritas.Manufacture method is with embodiment 1.
Embodiment 3: the raw material of selecting following weight parts: each 6.5 parts of Borneolum Syntheticum, Sanguis Draxonis, 40 parts of Margaritas.Manufacture method is with embodiment 1.
Embodiment 4: the raw material of selecting following weight parts: each 8.5 parts of Borneolum Syntheticum, Sanguis Draxonis, 50 parts of Margaritas.Manufacture method is with embodiment 1.
Embodiment 5: the raw material of selecting following weight parts: each 5 parts of Borneolum Syntheticum, Sanguis Draxonis, 30 parts of Margaritas, 2 parts of Radix Notoginseng, 1 part of Pseudobulbus Bletillae (Rhizoma Bletillae).Manufacture method is with embodiment 1.
Embodiment 6: the raw material of selecting following weight parts: each 10 parts of Borneolum Syntheticum, Sanguis Draxonis, 60 parts of Margaritas, 10 parts of Radix Notoginseng, 5 parts of Pseudobulbus Bletillae (Rhizoma Bletillae).Manufacture method is with embodiment 1.
Embodiment 7: the raw material of selecting following weight parts: each 6.5 parts of Borneolum Syntheticum, Sanguis Draxonis, 40 parts of Margaritas, 4 parts of Radix Notoginseng, 2 parts of Pseudobulbus Bletillae (Rhizoma Bletillae).Manufacture method is with embodiment 1.
Embodiment 8: the raw material of selecting following weight parts: each 8.5 parts of Borneolum Syntheticum, Sanguis Draxonis, 50 parts of Margaritas, 8 parts of Radix Notoginseng, 4 parts of Pseudobulbus Bletillae (Rhizoma Bletillae).Manufacture method is with embodiment 1.
Claims (5)
1, a kind of medicine for the treatment of skin ulceration is characterized in that being made by the raw material of following weight parts: each 5~10 parts of Borneolum Syntheticum, Sanguis Draxonis, 30~60 parts of Margaritas.
2, a kind of medicine for the treatment of skin ulceration according to claim 1 is characterized in that wherein crude drug also has: 2~10 parts of Radix Notoginseng, 1~5 part of Pseudobulbus Bletillae (Rhizoma Bletillae).
3, a kind of medicine for the treatment of skin ulceration according to claim 1 is characterized in that, it is characterized in that wherein the consumption of each component is: each 6.5~8.5 parts of Borneolum Syntheticum, Sanguis Draxonis, 40~50 parts of Margaritas.
4, a kind of medicine for the treatment of skin ulceration according to claim 3 is characterized in that wherein crude drug also has: 4~8 parts of Radix Notoginseng, 2~4 parts of Pseudobulbus Bletillae (Rhizoma Bletillae).
5, according to claim 1 or 2 or 3 or 4 described a kind of medicines for the treatment of skin ulceration, it is characterized in that: each composition medicine is ground to form fine powder, uniform mixing, sterilization after drying packing.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA2008101404331A CN101347559A (en) | 2008-07-02 | 2008-07-02 | Medicament for treating ulcer of skin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA2008101404331A CN101347559A (en) | 2008-07-02 | 2008-07-02 | Medicament for treating ulcer of skin |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101347559A true CN101347559A (en) | 2009-01-21 |
Family
ID=40266640
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2008101404331A Pending CN101347559A (en) | 2008-07-02 | 2008-07-02 | Medicament for treating ulcer of skin |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101347559A (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103919967A (en) * | 2014-04-03 | 2014-07-16 | 张荣平 | Dracaena cochinchinensis resin compound and application thereof in preparation of medicines for treating trauma |
CN104248694A (en) * | 2014-09-17 | 2014-12-31 | 金光 | Pharmaceutical composition and pharmaceutical preparation as well as application of pharmaceutical preparation |
CN105641007A (en) * | 2016-01-18 | 2016-06-08 | 刘景春 | Medicine for treating bedsores and postoperative infection |
CN106309815A (en) * | 2015-06-23 | 2017-01-11 | 陈静峰 | External ointment for burn and scald |
CN106421392A (en) * | 2016-11-02 | 2017-02-22 | 福元药业股份有限公司 | Traditional Chinese medicinal gel for treating bedsore and preparation method of traditional Chinese medicinal gel |
CN106975018A (en) * | 2017-06-05 | 2017-07-25 | 任建丰 | It is a kind of to treat Chinese medicine composition of skin ulcer and preparation method thereof |
CN108686078A (en) * | 2018-08-10 | 2018-10-23 | 贾玮 | A kind of traditional Chinese powder medicine for treating pressure sore |
CN111467433A (en) * | 2020-05-27 | 2020-07-31 | 中国人民解放军空军军医大学 | A topical Chinese medicinal composition and paste for promoting wound healing, and its preparation method |
CN111840436A (en) * | 2019-04-24 | 2020-10-30 | 程浩 | Traditional Chinese medicine ointment for treating animal trauma and preparation method thereof |
-
2008
- 2008-07-02 CN CNA2008101404331A patent/CN101347559A/en active Pending
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103919967B (en) * | 2014-04-03 | 2016-10-05 | 张荣平 | Sanguis Draxonis compound recipe and the application in preparation treatment more wound medicine thereof |
CN103919967A (en) * | 2014-04-03 | 2014-07-16 | 张荣平 | Dracaena cochinchinensis resin compound and application thereof in preparation of medicines for treating trauma |
CN104248694B (en) * | 2014-09-17 | 2018-05-15 | 金光 | Pharmaceutical composition and pharmaceutical preparation and its application |
CN104248694A (en) * | 2014-09-17 | 2014-12-31 | 金光 | Pharmaceutical composition and pharmaceutical preparation as well as application of pharmaceutical preparation |
CN106309815A (en) * | 2015-06-23 | 2017-01-11 | 陈静峰 | External ointment for burn and scald |
CN105641007A (en) * | 2016-01-18 | 2016-06-08 | 刘景春 | Medicine for treating bedsores and postoperative infection |
CN106421392A (en) * | 2016-11-02 | 2017-02-22 | 福元药业股份有限公司 | Traditional Chinese medicinal gel for treating bedsore and preparation method of traditional Chinese medicinal gel |
CN106975018A (en) * | 2017-06-05 | 2017-07-25 | 任建丰 | It is a kind of to treat Chinese medicine composition of skin ulcer and preparation method thereof |
CN106975018B (en) * | 2017-06-05 | 2020-05-05 | 任建丰 | A Chinese medicinal composition for treating skin ulcer, and its preparation method |
CN108686078A (en) * | 2018-08-10 | 2018-10-23 | 贾玮 | A kind of traditional Chinese powder medicine for treating pressure sore |
CN108686078B (en) * | 2018-08-10 | 2021-07-20 | 贾玮 | Traditional Chinese medicine powder for treating pressure sores |
CN111840436A (en) * | 2019-04-24 | 2020-10-30 | 程浩 | Traditional Chinese medicine ointment for treating animal trauma and preparation method thereof |
CN111467433A (en) * | 2020-05-27 | 2020-07-31 | 中国人民解放军空军军医大学 | A topical Chinese medicinal composition and paste for promoting wound healing, and its preparation method |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101347559A (en) | Medicament for treating ulcer of skin | |
CN101214286B (en) | Chinese medicine white spirit preparations for effectively treating rheumatic pain diseases | |
CN103230493B (en) | Traditional Chinese medicine composition for treating unhealed wound | |
CN104415265A (en) | Ointment for treating onychomycosis and preparation method thereof | |
CN101703651B (en) | Medicament for treating diabetic gangrene | |
CN107050118B (en) | Traditional Chinese medicine plaster for treating wind-cold-dampness arthralgia and preparation method thereof | |
CN101361876B (en) | Wound-healing tissue-promoting powder and preparation method thereof | |
CN103893557A (en) | Traditional Chinese medicine preparation for treating bedsore | |
CN103566071B (en) | Traditional Chinese medicine composition for treating ulcer and preparation method of powder of traditional Chinese medicine composition | |
CN111686152A (en) | External composition and gel for treating lymphedema and preparation method thereof | |
EP3369428A1 (en) | External traditional chinese medicine preparation for diminishing inflammation, relieving pain and promoting fast healing, and preparation method therefor | |
CN102727698B (en) | Wound surface nursing powder for treating bedsore | |
CN102872187B (en) | External carbuncle cream and preparation method thereof | |
CN104800280A (en) | Diabetes hand and foot wound heeling traditional Chinese medicine ointment and preparing method | |
CN111991471A (en) | A topical Chinese medicinal preparation for treating knife wound, burn and scald, and its preparation method | |
CN105233265A (en) | Composition capable of promoting wound healing | |
CN101194929A (en) | Powder medicament for treating decubitus | |
CN100475247C (en) | External application medicine for treating vertebrae lumbales hyperosteogeny | |
CN1191085C (en) | Quick-acting ointment for treating burns, scalds and knife wound | |
CN101164568B (en) | External-applied traditional Chinese medicine for treating hyperosteogeny | |
CN109010549A (en) | Synthetism expelling wind and activating blood flow pain relieving ointment and preparation method thereof | |
CN102343081A (en) | Moxibustion tool of pure Chinese medicinal preparation for treating bone aching and pure Chinese medicinal preparation for treating bone aching | |
CN102204966B (en) | Traditional Chinese medicine liniment for external use for relaxing muscles and tendons and alleviating pain | |
CN102078588B (en) | Medicinal composition for treating osteoproliferation and preparation method thereof | |
CN1236798C (en) | External medicine for treating bone tuberculosis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
AD01 | Patent right deemed abandoned |
Effective date of abandoning: 20090121 |
|
C20 | Patent right or utility model deemed to be abandoned or is abandoned |